EDIT Message Board Post 9191052 | Editas Medicine Inc.
home / stock / edit / edit message board
the1stbarbarian
(investorshub)
Posted on: Jul/15/2020 02:15:01
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156910302
I've heard they will publish preclinical data sometime
News, Short Squeeze, Breakout and More Instantly...
-
CAMBRIDGE, Mass., May 14, 2024 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ:EDIT), a clinical-stage gene editing company, today announced ...
-
CAMBRIDGE, Mass., May 14, 2024 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a clinical-stage gene editing company, today announced that two abstracts, including one oral presentation and one poster presentation, detailing clinical data from the RUBY and EdiTHAL trials of renizga...